CAR-T-Zell-Lymphomtherapie: Logistik und Toxizität zu meistern
Crossref DOI link: https://doi.org/10.1007/s15004-018-6288-9
Published Online: 2018-11-08
Published Print: 2018-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Leiner, Peter
Text and Data Mining valid from 2018-11-01
Article History
First Online: 8 November 2018